Residents of North Carolina can consult with the professionals at Klinic to determine which treatment aligns best with their lifestyle
The 2024 systematic review by Bu et al
[Schechter et al 2025, Zhang et al 2025, Wu et al 2025, Tang et al 2025] Semaglutide will slow disease progression of early-symptomatic AD at least to the level offered by anti-amyloid antibodies if not more solely on the basis of its ability to decrease weight, control BP, decrease peripheral inflammation, and control blood glucose levels
Ingredients Peptide complex (alanine, glutamic acid, asparagic acid, glycine), water, sodium benzoate, potassium sorbate
Key takeaways Insomnia is not a common side effect of semaglutide but some people have reported trouble sleeping while taking it